Immunicum AB (publ) Announces Upcoming Investor Events in October and November

Date : 10/22/2018 @ 3:00PM
Source : GlobeNewswire
Stock : Immunomedics, Inc. (IMMU)
Quote : 14.43  0.0 (0.00%) @ 11:59AM

Immunicum AB (publ) Announces Upcoming Investor Events in October and November

Press Release

22 October 2018

Immunicum AB (publ) Announces Upcoming Investor Events in October and November

Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session.   

BioStock Life Science Summit
Date: October 25, 2018
Presentation Time: 18.50 Central European Time
Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden
Registration Link:

Immunicum Investor Event - Gothenburg
Date: October 29, 2018
Presentation Time: 17.30 - 20.00 Central European Time
Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden

Immunicum Investor Event - Stockholm
Date: October 30, 2018
Presentation Time: 17.30 - 20.00 Central European Time
Venue: Ingenjörshuset Citykonferensen, Plan 1, Malmskillnadsgatan 46, 111 84 Stockholm, Sweden

RedEye Investor After Work Gothenburg
Date: November 12, 2018
Presentation Time: 18.00 Central European Time
Venue: Elite Park Avenue, Gothenburg, Sweden

RedEye Life Science Day
Date: November 21, 2018
Presentation Time: 8.40 Central European Time
Venue: Haymarket by Scandic, Stockholm, Sweden

Aktiespararna - Stora Aktiedagen
Date: November 26, 2018
Presentation Time: 8.40 - 9.10 Central European Time
Venue: Sheraton Hotel Stockholm, Tegelbacken 6, Stockholm, Sweden

Erik Penser Bank - Bolagsdag
Date: November 28, 2018
Presentation Time: 13.00 pm Central European Time
Venue: Apelbergsgatan 27, Stockholm, Sweden

To register to attend the Immunicum Investor events, please send an email to with your full name and the selected location (Gothenburg or Stockholm).

For more information, please contact:

Carlos de Sousa, CEO, Immunicum
Telephone: +46 (0) 31 41 50 52

Michaela Gertz, CFO, Immunicum
Telephone: +46 70 926 17 75

Media Relations

Gretchen Schweitzer and Joanne Tudorica
Trophic Communications
Telephone: +49 172 861 8540

About Immunicum AB (publ) Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies. Our goal is to improve survival outcomes and quality of life by priming the patient's own immune system to fight cancer. The company's lead product ilixadencel, consisting of pro-inflammatory allogeneic dendritic cells, has the potential to become a backbone component of modern cancer combination treatments in a variety of solid tumor indications. Founded and based in Sweden, Immunicum is publicly traded on the Nasdaq Stockholm.

20181022_Immunicum_Oct-Nov Conferences_ENG

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Immunicum AB via Globenewswire

Immunomedics (NASDAQ:IMMU)
Historical Stock Chart

1 Year : From May 2018 to May 2019

Click Here for more Immunomedics Charts.

Immunomedics (NASDAQ:IMMU)
Intraday Stock Chart

Today : Friday 24 May 2019

Click Here for more Immunomedics Charts.

Latest IMMU Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.